JOHN MANALOOR to Infant
This is a "connection" page, showing publications JOHN MANALOOR has written about Infant.
Connection Strength
0.154
-
Susceptibility Provision Enhances Effective De-escalation (SPEED): utilizing rapid phenotypic susceptibility testing in Gram-negative bloodstream infections and its potential clinical impact. J Antimicrob Chemother. 2019 01 01; 74(Suppl 1):i16-i23.
Score: 0.052
-
Hepatitis A, B, and C. Pediatr Rev. 2016 Oct; 37(10):426-438.
Score: 0.045
-
Assessing the Diagnostic Performance and Clinical Utility of Nasal Methicillin-Resistant Staphylococcus aureus PCR Testing in Pediatric Orbital Cellulitis. J Pediatric Infect Dis Soc. 2024 Aug 24; 13(8):430-433.
Score: 0.019
-
Comparison of Risk of Recrudescent Fever in Children With Kawasaki Disease Treated With Intravenous Immunoglobulin and Low-Dose vs High-Dose Aspirin. JAMA Netw Open. 2020 01 03; 3(1):e1918565.
Score: 0.014
-
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease. Contemp Clin Trials. 2019 04; 79:98-103.
Score: 0.013
-
Photo quiz: Diarrhea and fever in a child returning from Africa. Answer to photo quiz: Enteric fever. J Clin Microbiol. 2015 Apr; 53(4):1053, 1461.
Score: 0.010